Grace Therapeutics, Inc.
Pharmaceutical Preparations | SIC: 2834Phone: 609-322-1602
State Location: NJ
State of Inc.: DE
- Nasdaq:GRCE
Form: 8-K
Filing Date: 23 Jun 2025Report Date: 23 Jun 2025
Accepted: 23 Jun 2025 10:00 a.m.
Accession Number: 0001140361-25-023261
File Number: 001-35776
Film Number: 251062992
Items: 2.02,9.01
Documents
Primary Document: 8-K
Accepted: 23 Jun 2025 10:00 a.m.
0001140361-25-023261-index-headers.html
Last Modified: 23 Jun 2025 06:00 a.m.
0001140361-25-023261-index.html
Last Modified: 23 Jun 2025 06:00 a.m.
0001140361-25-023261-xbrl.zip
Last Modified: 23 Jun 2025 06:00 a.m.
0001140361-25-023261.txt
Last Modified: 23 Jun 2025 06:00 a.m.
FilingSummary.xml
Last Modified: 23 Jun 2025 06:00 a.m.
MetaLinks.json
Last Modified: 23 Jun 2025 06:00 a.m.
R1.htm
Last Modified: 23 Jun 2025 06:00 a.m.
Show.js
Last Modified: 23 Jun 2025 06:00 a.m.
ef20050698_8k_htm.xml
Last Modified: 23 Jun 2025 06:00 a.m.
ef20050698_ex99-1.htm
Last Modified: 23 Jun 2025 06:00 a.m.
grce-20250623.xsd
Last Modified: 23 Jun 2025 06:00 a.m.
grce-20250623_lab.xml
Last Modified: 23 Jun 2025 06:00 a.m.
grce-20250623_pre.xml
Last Modified: 23 Jun 2025 06:00 a.m.
image00001.jpg
Last Modified: 23 Jun 2025 06:00 a.m.
report.css
Last Modified: 23 Jun 2025 06:00 a.m.